Search for: "A-P-T Research, Inc." Results 221 - 240 of 798
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Mar 2014, 8:37 pm by Schachtman
Crane Co., et al., No. 10C-08-216, Delaware Superior Court, New Castle Cty., at p. 152 (June 11, 2012). [read post]
4 Apr 2023, 5:01 am by Eugene Volokh
Shannon & Wilson, Inc., 564 P.2d 1131 (Wash. 1977). [3] Story v. [read post]
12 Apr 2012, 10:56 am by Bexis
[P]romotion of the off-label uses of a FDA-approved drug concerns lawful activity and is not inherently misleading. . . . [read post]
17 Feb 2016, 9:20 am by Dennis Crouch
Lee, Director, United States Patent and Trademark Office, No. 15-326 I/P Engine, Inc. v. [read post]
14 Feb 2013, 12:30 am by Dave Wieneke
And when it comes to  product road maps, not even the most expert opinion can’t replace fact-based research on actual consumers. [read post]
4 Feb 2008, 8:23 am
Sony Electronics, Inc., No. 05-1741, 2007 U.S. [read post]
7 May 2015, 9:04 am by WIMS
Senators Tammy Baldwin (D-WI), Maria Cantwell (D-WA), Chuck Schumer (D-NY), Robert P. [read post]
16 Jan 2011, 7:36 am by Vincent LoTempio
IFI CLAIMS® Patent Services, a division of Fairview Research, compiled a ranking of global companies awarded the most U.S. patents in 2010. [read post]
4 Nov 2013, 9:08 am
Zimmer, Inc., 299 P.3d 463 (Okla. 2013), could be used to expand traditional tort causes of action under Oklahoma law in all sorts of novel and bizarre ways.Well, we still have that general concern, but if Clineis any indication, off-label use is not going to be one of those areas. [read post]
14 May 2010, 4:00 am by FDABlog HPM
District Court for the District of New Jersey (King Pharmaceuticals Inc., King Pharmaceuticals Research and Development Inc., Pharmaceutical IP Holding Inc. v. [read post]